PAMP
EWTX icon

Polar Asset Management Partners’s Edgewise Therapeutics EWTX Stock Holding History

Polar Asset Management Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64,279
Closed -$1.72M – 605
2024
Q4 		$1.72M Sell
64,279
-93,300
-59% -$2.97M 0.02% 369
2024
Q3 		$4.21M Sell
157,579
-29,921
-16% -$595K 0.09% 220
2024
Q2 		$3.38M Buy
+187,500
New +$3.27M 0.07% 248

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Polar Asset Management Partners's EWTX Position: Q1 2025 in Review

Polar Asset Management Partners sold out of Edgewise Therapeutics (EWTX) in Q1 2025, closing a stake of 64,279 shares — an estimated $1.72M sold.

Polar Asset Management Partners first reported a position in EWTX in Q2 2024 and held it in 3 quarters. The position peaked at $4.21M in Q3 2024. 192 funds tracked by Wall St. Rank hold EWTX as of Q1 2025.

  • Polar Asset Management Partners reported no remaining Edgewise Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Polar Asset Management Partners sold 64,279 Edgewise Therapeutics shares in Q1 2025, an estimated $1.72M.
  • Polar Asset Management Partners first reported a position in Edgewise Therapeutics in Q2 2024 and held it in 3 quarters.
  • Polar Asset Management Partners's Edgewise Therapeutics position peaked at $4.21M in Q3 2024.
  • 192 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2025.

Based on Polar Asset Management Partners's 13F filing for Q1 2025, filed 15 May 2025.